China CDC Engineered Chimeric Chikungunya Virus Vector Year Before Guangdong Outbreak: 'Virology Journal'
Guangdong's chikungunya outbreak spiked immediately after government mosquito-spraying campaigns—potentially echoing DARPA's pre-COVID-19 pandemic aerosol release scenario.
Summary
In the year leading up to Guangdong’s 2025 chikungunya outbreak, Chinese government-linked scientists at the China CDC engineered a bivalent recombinant adenovirus vector carrying genes from both West Nile virus and chikungunya virus (CHIKV). The chikungunya genes—E3, E2, 6K, and E1—were taken from a live-attenuated CHIKV strain (181/clone25) and inserted into a human adenovirus type 5 backbone.
Funding for this work came from the National Key R&D Program of China and the National Natural Science Foundation of China. All experiments, from vector construction to animal trials, were performed in Chinese laboratories, including the National Institute for Viral Disease Control and Prevention (China CDC) in Beijing.
This mirrors the pattern seen before the COVID-19 pandemic, when Chinese and U.S.-funded researchers were conducting coronavirus gain-of-function experiments in the years immediately preceding the first reported SARS-CoV-2 cases.
In early July 2025, Guangdong authorities carried out mass mosquito spraying campaigns, followed within weeks by the largest spike in chikungunya cases ever recorded in the province.
Though speculative, this sequence aligns disturbingly with scenarios outlined in the 2018 DARPA DEFUSE proposal, which described pre-outbreak aerosol spraying of biological materials over human populations.
Timeline
March 9, 2023: China CDC’s Animal Ethics and Use Committee approves protocol 20230309023 for animal experiments with a bivalent Ad5 vaccine containing West Nile virus prM-E and chikungunya virus E3-E2-6K-E1 genes from the live-attenuated CHIKV 181/clone25 strain.
March 2023–Late 2024: Vaccine engineered and tested in Chinese facilities, including the National Institute for Viral Disease Control and Prevention (China CDC), Hebei Medical University, Xinxiang Medical University, and Wenzhou Medical University.
February 20, 2025: Paper describing the chimeric Ad5-WNV-CHIKV construct and immune results in mice is received by Virology Journal.
June 16, 2025: Earliest recorded symptom onset in the Foshan chikungunya outbreak.
July 9, 2025: Outbreak officially reported by Chinese health authorities.
Early July 2025: Guangdong government conducts large-scale mosquito spraying operations in Foshan and surrounding areas under “vector control” programs.
July 19: 681 cases recorded.
Late July 2025: Thousands of confirmed chikungunya cases reported in Foshan, Guangdong Province.
China Engineered a Chimeric Chikungunya Virus Vector Before the Outbreak
The Virology Journal paper, “Humoral and cellular immune response to a single dose of a novel bivalent recombinant adenovirus-vector vaccine against West Nile virus and chikungunya virus in mice,” describes laboratory creation of a new viral vector containing chikungunya surface protein genes:
“The prM-E coding gene of WNV … and E3-E2-6 K-E1 coding gene from CHIKV (CHIKV 181/clone25) were linked in tandem using a 2A peptide… The live attenuated CHIKV 181/clone25 virus was provided by Professor Zhang,” the paper reads.
While labeled as a “vaccine platform,” the resulting Ad5-WNV-CHIKV virus gained the new function of producing authentic chikungunya surface proteins inside infected mammalian cells.
In theory, this same system could be repurposed for viral pseudotyping or chimeric virus creation if combined with other backbones.
The Case Spike After Government Spraying
The largest surge in chikungunya cases in Guangdong occurred in mid-July 2025, about 10 days after alleged insecticide spraying and mosquito control began immediately following the official outbreak announcement on July 9.
China’s CDC reported:
On July 9, 2025, Foshan City, Guangdong Province reported a cluster of CF cases. As of July 26, a total of 4,824 confirmed cases had been reported (5) across 12 prefecture-level cities in Guangdong, with 4,754 cases (98.5%) occurring in Foshan and 70 cases (1.5%) distributed among the other 11 prefectures. The majority of cases were concentrated in Shunde District of Foshan, which accounted for 4,208 cases (87.2% of all provincial cases).
Among the confirmed cases, the earliest symptom onset date was June 16. Daily case reports reached their peak on July 19, with 681 cases recorded. The male-to-female ratio was 1:0.97, and the median age was 44 years (range: 0–95 years). Adults aged 15–64 years comprised the largest proportion of cases (3,229 cases; 66.9%), followed by older adults aged ≥65 years (940 cases; 19.5%), school-aged children aged 5–14 years (546 cases; 11.3%), and young children under 5 years (109 cases; 2.3%).
…
Simultaneously, comprehensive vector control measures were implemented across affected communities. Targeted adulticide spraying and systematic elimination of mosquito breeding sites were conducted within a minimum 100-meter radius of confirmed case residences, workplaces, and frequently visited locations. Real-time vector surveillance using the Breteau Index and Area Density Index provided critical metrics to assess and optimize transmission control effectiveness.
The Associated Press reported:
Chinese authorities are using nets, spraying insecticide and even deploying drones to fight the mosquito-borne chikungunya virus, which has infected thousands of people.
…
Unusually heavy rains and high temperatures have worsened the crisis in China, and authorities are using drones to try to find standing water, where mosquitoes lay eggs.
This mirrors a detail in the 2018 DARPA DEFUSE proposal, in which EcoHealth Alliance and partners outlined plans for “aerosolized inoculation” of human and animal populations prior to anticipated outbreaks—framed as preemptive protection.
While Guangdong’s spraying was officially for mosquito control, its timing relative to the outbreak spike raises questions, especially given documented government interest in aerosol-based biological delivery mechanisms.
Bottom Line
What we know is that Chinese CDC–linked laboratories engineered a chimeric adenovirus carrying live-attenuated chikungunya virus structural genes more than a year before an actual outbreak in the same province.
Mass spraying operations took place just before the case surge, in a sequence that parallels known aerosol-based pre-outbreak delivery models.
The overlap of pre-outbreak genetic engineering, government spraying, and a sudden large-scale epidemic could be considered a red flag—especially in light of DARPA’s documented strategies for aerosol-based pathogen deployment.
Taken together, the timing, the technology, and the tactics point to a chilling possibility—that what unfolded in Guangdong was not merely an unfortunate convergence of events, but the execution of a playbook written long before the first case appeared.
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities reaching 230,000+ monthly viewers, contact us by clicking below.
Interesting speculations.
You appear to be pointing out that ostensible government narratives serve to legitimate the use of unconventional weapons against the population.
Such as "climate crisis" legitimating weather warfare as - arson (as various secret technologies), -cloud seeding, artificial flooding and high winds. etc
"Pandemics" legitimating the injection of untested drugs into the population masquerading as therapies, "environmental virus threats" legitimating the spraying by drone of "pesticides" on the population, the execution of most of the UK dairy herds because of "foot and mouth" and the repossession of the bankrupted farmers' land.....
There is no limit to the false stories they can come up with to allow them to do as they wish.. I am sure your readers can contribute many more examples.
Mad scientists creating monsters. What a horror. They all should be shut down planet wide.